Published in Cancer Weekly, May 23rd, 2000
This study, conducted by P. Sundaresan and others at the University, was published recently in the Journal of Virology ("Attenuated, replication-competent herpes simplex virus type 1 mutant G207: Safety evaluation in mice," J Virol, 2000;74(8):3832-3841).
Commenting on the study, Sundaresan and colleagues said, "Herpes simplex virus type 1 (HSV-1) mutants that are attenuated for neurovirulence are being used for the treatment of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.